Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lizzia Raffaghello

Showing results (11-20 of 86) with videos related to

Pageof 9
Sort By:
Histology and Histopathology|June 2, 2011
Immunosuppressive cells and tumour microenvironment: focus on mesenchymal stem cells and myeloid derived suppressor cellsGiovanna Bianchi, Giacomo Borgonovo, Vito Pistoia, et al.
Immunotherapy|July 15, 2011
Cytokines in neuroblastoma: from pathogenesis to treatmentVito Pistoia, Giovanna Bianchi, Giacomo Borgonovo, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|June 24, 2008
Immunological mechanisms in opsoclonus-myoclonus associated neuroblastomaLizzia Raffaghello, Massimo Conte, Elisa De Grandis, et al.
Frontiers in Oncology|November 20, 2012
MYCN: from oncoprotein to tumor-associated antigenVito Pistoia, Fabio Morandi, Annalisa Pezzolo, et al.
Seminars in Cancer Biology|November 18, 2008
Chemokines in neuroectodermal tumour progression and metastasisLizzia Raffaghello, Claudia Cocco, Maria Valeria Corrias, et al.
Cancer Research|January 21, 2006
The P2X7 receptor sustains the growth of human neuroblastoma cells through a substance P-dependent mechanismLizzia Raffaghello, Paola Chiozzi, Simonetta Falzoni, et al.
Frontiers in Oncology|June 28, 2013
Immunosuppressive microenvironment in neuroblastomaVito Pistoia, Fabio Morandi, Giovanna Bianchi, et al.
Plos One|July 30, 2010
A novel mechanism of soluble HLA-G mediated immune modulation: downregulation of T cell chemokine receptor expression and impairment of chemotaxisFabio Morandi, Elisa Ferretti, Paola Bocca, et al.
Frontiers in Immunology|July 18, 2025
Medulloblastoma: biology and immunotherapyAlessandro Poggi, Francesco Reggiani, Helena S Azevedo, et al.
Oncotarget|October 27, 2017
Targeting of <i>PHOX2B</i> expression allows the identification of drugs effective in counteracting neuroblastoma cell growthEleonora Di Zanni, Giovanna Bianchi, Roberto Ravazzolo, et al.
Pageof 9

Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
Histology and Histopathology|June 2, 2011
Immunosuppressive cells and tumour microenvironment: focus on mesenchymal stem cells and myeloid derived suppressor cellsGiovanna Bianchi, Giacomo Borgonovo, Vito Pistoia, et al.
Immunotherapy|July 15, 2011
Cytokines in neuroblastoma: from pathogenesis to treatmentVito Pistoia, Giovanna Bianchi, Giacomo Borgonovo, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|June 24, 2008
Immunological mechanisms in opsoclonus-myoclonus associated neuroblastomaLizzia Raffaghello, Massimo Conte, Elisa De Grandis, et al.
Frontiers in Oncology|November 20, 2012
MYCN: from oncoprotein to tumor-associated antigenVito Pistoia, Fabio Morandi, Annalisa Pezzolo, et al.
Seminars in Cancer Biology|November 18, 2008
Chemokines in neuroectodermal tumour progression and metastasisLizzia Raffaghello, Claudia Cocco, Maria Valeria Corrias, et al.
Cancer Research|January 21, 2006
The P2X7 receptor sustains the growth of human neuroblastoma cells through a substance P-dependent mechanismLizzia Raffaghello, Paola Chiozzi, Simonetta Falzoni, et al.
Frontiers in Oncology|June 28, 2013
Immunosuppressive microenvironment in neuroblastomaVito Pistoia, Fabio Morandi, Giovanna Bianchi, et al.
Plos One|July 30, 2010
A novel mechanism of soluble HLA-G mediated immune modulation: downregulation of T cell chemokine receptor expression and impairment of chemotaxisFabio Morandi, Elisa Ferretti, Paola Bocca, et al.
Frontiers in Immunology|July 18, 2025
Medulloblastoma: biology and immunotherapyAlessandro Poggi, Francesco Reggiani, Helena S Azevedo, et al.
Oncotarget|October 27, 2017
Targeting of <i>PHOX2B</i> expression allows the identification of drugs effective in counteracting neuroblastoma cell growthEleonora Di Zanni, Giovanna Bianchi, Roberto Ravazzolo, et al.
Pageof 9